Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma (Q48264845)
scientific article published in February 2007
Language:
Current Data About Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
(P31) (Q13442814)
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(P50) (Q73422966)
(P1545) 13
(P1932) Henry S Friedman
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018

(Q57195229)
(P1545) 11
(P1932) Darell D Bigner
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018

(Q73536128)
(P1545) 9
(P1932) Sridharan Gururangan
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018

(Q73536038)
(P1545) 2
(P1932) Annick Desjardins
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018

(Q4730609)
(P1545) 12
(P1932) Allan H Friedman
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018

(Q73570385)
(P1545) 5
(P1932) David A Reardon
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018

(Q92482497)
(P1545) 7
(P1932) Jeremy N Rich
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(Q90965375)
(P1545) 6
(P1932) Jennifer A Quinn
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(Q114444381)
(P1545) 1
(P1932) James J Vredenburgh
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(Q112381232)
(P1545) 3
(P1932) James E Herndon
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(Q96144364)
(P1545) 8
(P1932) Sith Sathornsumetee
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(Q114574393)
(P1545) 4
(P1932) Jeannette M Dowell
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(Q97429926)
(P1545) 10
(P1932) Melissa Wagner
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(P304) 1253-1259
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(P407) (Q1860)

(P433) 4
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(P478) 13
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(P577) Thursday, February 1, 2007
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(P921) (Q42824440)

(Q413299)
(P887)

(Q412197)
(P887)

(P1433) (Q332253)
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

(P1476) "Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma" (language: en)
(P248)
(P698) 17317837
(P813) Saturday, February 10, 2018
(P854) http://europepmc.org/abstract/MED/17317837

other details
description scientific article published in February 2007

External Links
(P356) 10.1158/1078-0432.CCR-06-2309
(P698) 17317837